European Healthtech startup funding raised during H1 2019.
In H1 2019, 142 European Healthtech companies raised a combined €1.8B across 142 funding rounds, up 112.0% versus H1 2018. UK led by capital raised, and University of Cambridge Enterprise was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Babylon | Other | Jun 2019 | €483M |
| CMR Surgical | Series C | Jun 2019 | €218M |
| docplanner | Series D+ | Mar 2019 | €80M |
| Bioserenity | Series B | Mar 2019 |
11 exits · €424M disclosed.
| InMode | IPO | Feb 2019 | €384M |
| EXIMO MEDICAL | Acquisition | Apr 2019 | €40M |
| €65M |
| PolyPid | Series D+ | Jun 2019 | €44M |
| Quanta | Series C | Jun 2019 | €42M |
| iSTAR Medical | Series C | Jun 2019 | €40M |
| Promethera Biosciences | Series D+ | Mar 2019 | €40M |
| Imcyse | Series B | Mar 2019 | €35M |
| DNA Script | Series B | Mar 2019 | €34M |
| Confo Therapeutics | Series A | Mar 2019 | €30M |
| Micreos | Other | Mar 2019 | €30M |
| Microphyt | Other | Jun 2019 | €29M |
| Zava | Series A | Mar 2019 | €28M |
| DayTwo | Series B | Mar 2019 | €28M |
